ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression.

导出原文传递

翻译打印收藏纠错

第一作者： Lifang,Li

第一单位： Department of Cancer Cell Biology, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. lifangli@bjmu.edu.cn.

作者： Lifang,Li ^[1] ; Xuefei,Wang ^[2] ; Kai,Hu ^[3] ; Xinhua,Liu ^[4] ; Li,Qiu ^[2] ; Changsen,Bai ^[5] ; Yanfen,Cui ^[6] ; Biyun,Wang ^[7] ; Zhaosong,Wang ^[7] ; Hailong,Wang ^[2] ; Runfen,Cheng ^[2] ; Jialei,Hua ^[2] ; Linyue,Hai ^[2] ; Mengdie,Wang ^[2] ; Miao,Liu ^[2] ; Zian,Song ^[2] ; Chunhua,Xiao ^[8] ; Binghui,Li ^[9]

作者单位： Department of Cancer Cell Biology, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. lifangli@bjmu.edu.cn. ^[1] Department of Cancer Cell Biology, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. ^[2] Department of Pathology, School of Medicine, Nankai University, Tianjin, 300071, PR China. ^[3] Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, PR China. ^[4] Department of Clinical Laboratory, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. ^[5] Public Laboratory, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. ^[6] Laboratory Animal Center, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. ^[7] First Surgical Department of Breast Cancer, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. xxcchh2002@163.com. ^[8] Department of Cancer Cell Biology, Tianjin's Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, PR China. bli@ccmu.edu.cn. ^[9] Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, PR China. bli@ccmu.edu.cn. ^[10]